HAEMOPHILIA: AN OVERVIEW

Authors

  • Lokesh Kumar Nagar Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Neha Sharma Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • M. P. Khinchi Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Mohd. Shahid Khan Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Atul Kumar Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Keywords:

Haemophillia, Human body fluids, Requirments

Abstract

Haemophilia also called hemophilia, is a mostly inherited, genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding longer after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with mild disease may only have symptoms after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or a decreased level of consciousness.There are two main types of haemophilia, haemophilia A due to not enough clotting factor VIII and haemophilia B due to not enough clotting factor IX. They are typically due to inheriting from one's parents an X chromosome with a non functional gene.

Downloads

Download data is not yet available.

Published

2017-03-01

How to Cite

Nagar, L. K., Sharma, N., Khinchi, M. P., Khan, M. S., & Kumar, A. (2017). HAEMOPHILIA: AN OVERVIEW. Asian Journal of Pharmaceutical Research and Development, 5(2), 1–10. Retrieved from https://www.ajprd.com/index.php/journal/article/view/293

Issue

Section

Review Articles

Most read articles by the same author(s)

1 2 3 4 5 > >>